A not-for-profit organisation supporting ophthalmic research
As part of its 20-year celebrations, Vision Eye Institute – one of Australia’s largest providers of ophthalmic services – is excited to launch the Future Vision Foundation.
Vision Eye Institute has a deep heritage in ophthalmic research to acquire new knowledge and improve patient care. The not-for-profit Future Vision Foundation extends this commitment further by encouraging and supporting the research efforts of staff and associated clinicians (including those with little-to-no formal research experience).
The Foundation has been a dream since Vision Eye Institute first began – born from a shared desire by many of us to improve diagnosis, to improve treatments and to improve healthcare experiences for patients with eye conditions. We are now thrilled to see it come to life.
Under the guidance of our esteemed board of directors, we look forward to working alongside other organisations within ophthalmology, optometry and industry and contributing to the excellent research already being undertaken in Australia.
Associate Professor Tim Roberts
Chairman, Future Vision Foundation
National Medical Director, Vision Eye Institute
We acknowledge the Traditional Custodians of the land upon which we work and care for patients, and their Elders past, present and future.
We foster the next generation of eye care researchers. We use our passion, expertise and resources to invest in and support innovative research to improve patient outcomes and healthcare experiences within clinical ophthalmology.
We believe it all starts with passion. A passion for patient care. A passion to contribute. A passion for research.
We embrace a culture of teamwork.
We invest in the future. The future of ophthalmic care.
We look for new, unexplored pathways to improve healthcare outcomes and experiences for patients.
We are ethical, honest and transparent in everything we do.
We ensure all research we support is underpinned by scientific excellence and evidence.
The Future Vision Foundation is now warmly inviting applications for research support in the areas of clinical and scientific ophthalmology.
We are pleased to offer:
Proposals must be accompanied by a robust study design, feasibility, analysis and presentation strategy, and Human Research Ethics Committee (HREC) approval if applicable.
Investigators should expect to present their data at leading national and international conferences, as well as publish their findings in Q1 peer-reviewed journals.
We are a not-for-profit research foundation. In addition to funding provided by Vision Eye Institute, the Future Vision Foundation relies on contributions from other organisations and suppliers. If you are interested in making a donation to support ophthalmic research, please contact us for more information.
Dr Tim Roberts is National Medical Director of Vision Eye Institute, Clinical Associate Professor of Ophthalmology at the University of Sydney Medical School and Consultant Ophthalmic Surgeon at the Royal North Shore Hospital, where he heads the glaucoma unit. He is a highly regarded cataract and glaucoma specialist, with clinical interests in the development and utilisation of new and innovative technologies in ophthalmology, medical ethics and education.
Dr Roberts serves on the editorial board for the American Academy of Ophthalmology textbook Lens and Cataract, is Cataract Section Editor for Clinical & Experimental Ophthalmology and the Asia-Pacific Journal of Ophthalmology, and sits on various government, industry and professional advisory boards.
Ms Davies is Chief Executive Officer of the Australian Medical Association (NSW) Limited. Fiona joined AMA (NSW) in June 1998. She has a Bachelor of Business from the University of Technology, Sydney and a Master of Business in Employment Relations, also from the University of Technology, Sydney.
During her employment with AMA (NSW), Fiona has been Industrial Officer and Manager, Workplace Relations and Director of Medico Legal and Workplace Relations. As Chief Executive Officer of AMA (NSW), Fiona is responsible to Council for the overall administration of AMA (NSW) and specifically deals with liaison between AMA (NSW) and State Government, AMA (NSW) and Federal AMA, and the broader aspects of medico-political issues.
A former long-serving senior manager with the global technology firm ZEISS, Mr Redner has extensive commercial experience in the optical, medical and scientific research fields.
During his tenure with ZEISS, Joe served as Managing Director of ZEISS Australasia, President of the US-based Carl Zeiss Meditec Inc. and Head of Sales, Ophthalmology, APAC, in addition to spending several years working at the corporate headquarters in Germany.
Mr Sexton is a Chartered Accountant with over 20 years’ experience across numerous well-known companies. He is an accomplished Chief Financial Officer (CFO) with a proven track record of adding commercial and operational value, executing strategic outcomes and enacting positive business change.
Before joining Vision Eye Institute, Peter was CFO of Ramsay Pharmacy Group, the centralised pharmacy division of Ramsay Health Care. Here he oversaw substantive business transformation and creation through a large-scale acquisition program and strong organic growth.
Peter started his career at Ernst & Young, after which he spent time in London at leading investment banks. On his return to Australia, he managed the finance team of Village Roadshow Production Group (part of Village Roadshow Limited). He then went on to lead the management consulting division of a boutique consultancy firm.
In late 2019, Peter commenced his role as CFO of Vision Eye Institute where he aims to utilise his wealth of experience to add value, drive strategy and help grow the organisation.
Professor Stapleton was awarded her PhD from City University and Moorfields Eye Hospital in London for her research on the pathogenesis and epidemiology of contact lens-related disease and completed a post-doctoral fellowship at University College London.
Fiona is a clinical scientist with expertise in epidemiology and clinical research in the fields of corneal infection, dry eye and contact lens-related disease. She holds numerous memberships and executive affiliations with scientific organisations, is a regular reviewer for a range of journals, belongs to the international editorial board of three journals, has over 280 peer-reviewed publications, has contributed 20 chapters to textbooks and published one book. She is currently President of the International Society for Contact Lens Research and was awarded Fellowship of the Australian Academy of Science and Technology in 2018.
Mr Thiedeman has spent over 30 years working in healthcare in both the public and private sectors. He joined Vision Eye Institute in 2017 as Chief Executive Officer (CEO) and Managing Director. James is ultimately responsible for ensuring Vision Eye Institute delivers the highest quality of care to its patients and that the organisation delivers on its strategic priorities.
Immediately prior to joining Vision Eye Institute, James was the Group CEO and Managing Director of Monash IVF Group (ASX:MVF) for eight years. Monash IVF Group is one of the most respected fertility care providers in Australia and the world.
Over his career in healthcare, James has been the CEO of Noosa Private Hospital on Queensland’s Sunshine Coast and held senior roles with Ramsay Health Care, Affinity Health, Mayne Health and Health Care of Australia. Before moving to the private health industry, James held senior policy and planning positions in the public sector with the Queensland Department of Health.
James holds a Bachelor of Business (Health Administration) from Queensland University of Technology and a Master of Business Administration (MBA) from Griffith University. He is also a member of the Australian Institute of Company Directors.
Ms Lopreiato joined Vision Eye Institute in 2011 as Company Secretary. She is responsible for supporting the Vision Eye Institute Board and its directors, ensuring the company’s compliance with the Corporations Act and overseeing corporate governance within the organisation generally.
Before joining Vision Eye Institute, she held Company Secretary or Secretariat Manager roles at several large ASX-listed corporations, including Symbion Health Limited, Mayne Pharma Limited, Mayne Group Limited and Colonial Limited. There she was involved with a number of strategic initiatives and projects, including mergers and acquisitions activity and capital raising, along with the usual secretariat responsibilities.
Karen holds a Bachelor of Commerce from the University of Western Australia and a Graduate Diploma in Applied Corporate Governance. She is a Fellow of Governance Institute of Australia.
Ms Searle has been part of the Vision Eye Institute family for over 16 years. She is currently the General Manager of Operations for New South Wales and North Queensland, with oversight of the consulting and laser practices. Cathie enjoys seeing every member of the Vision Eye Institute team contributing to the organisation’s mission – ‘Transforming lives, that’s our vision.’
Prior to joining Vision Eye Institute, Cathie held a clinical role as an orthoptist at the Royal Alexandra Hospital for Children. After being appointed Deputy Director of Administrative Services, she formed part of the team that oversaw the hospital’s relocation to its new facility, The Children’s Hospital at Westmead (CHW). Project management of the construction of Ronald McDonald House, Westmead and Bear Cottage, were other significant responsibilities during her tenure with CHW.
Cathie has a Master of Health Administration from the University of New South Wales and a Diploma of Applied Science (Orthoptics) from Cumberland College of Health Sciences.
As the Clinical Research Coordinator at Vision Eye Institute, Dr Chris Hodge has led more than 30 pharmaceutical-sponsored clinical trials across clinics, developing significant experience and understanding of trial procedures and good clinical practice (ICH/GCP) regulations. Obtaining his PhD through research in 2015, he has published over 120 articles in peer-reviewed scientific literature. Over the past 5 years, he has been a co-investigator in successful research grants totalling over $3M.
Chris also holds the part-time position of Data & Innovations Officer at NSW Tissue Bank and is a member of several research groups at the University of Sydney. Since 2019, he has been a member of the NSW Organ & Tissue Donation Service (NSW OTDS) Research Steering Committee to review and recommend research undertaken across the NSW OTDS. He has been a member of the University of Technology Sydney (UTS) Industry Advisory Board for the Graduate School of Health (Faculty of Orthoptics) since the course moved to the university in 2014 and has supervised Master’s and PhD students through to graduation at both the University of Sydney and UTS, highlighting a commitment to education and the development of research.
Please fill in the form below to ask a question.
As one of Australia’s largest private ophthalmology providers (and operator of ten day surgeries through Vision Hospital Group), Vision Eye Institute is committed to delivering world-class healthcare. Every year, our clinics and day surgeries in VIC, NSW, QLD and SA provide care for over 100,000 metropolitan and regional patients. Our dedicated doctors and support staff combine years of clinical expertise and an extensive research and teaching program to ensure patients receive best-practice care.
The Future Vision Foundation is an initiative of Vision Eye Institute through its OneVision environmental, social and governance (ESG) program.